In a comparative setting with ovalbumin (OVA)-specific TCRs, OT-I T cells with CARD11-PIK3R3 gene fusion outgrew regular OT-I T cells by over 100-fold when co-administered into B16-OVA tumor-bearing mice. Here, PIK3R3 is linked to neoplasm.